ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,335Medicare Part D Prescriptions Filled, Including Refills

Rank: 1001 out of 3647

$472K Total Retail Price of All Prescriptions

Rank: 1209 out of 3647

307 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 307 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 307 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 8,301 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 365 332 1 5
AMLODIPINE BESYLATE 353 327 2 2
SIMVASTATIN 303 293 3 1
LISINOPRIL 285 265 4 4
TRAMADOL HCL 248 221 5 22
OMEPRAZOLE 243 222 6 3
FUROSEMIDE 239 233 7 8
METOPROLOL TARTRATE 219 213 8 7
MIRTAZAPINE 201 195 9 63
GABAPENTIN 195 179 10 17
POTASSIUM CHLORIDE 181 158 11 24
METOCLOPRAMIDE HCL 133 115 12 135
CARVEDILOL 130 113 13 20
HYDRALAZINE HCL 128 125 14 81
FAMOTIDINE 125 95 15 61
NAMENDA 120 120 16 49
DONEPEZIL HCL 109 99 17 30
CLOPIDOGREL 105 101 18 26
WARFARIN SODIUM 105 95 18 15
NOVOLIN R 105 91 18 139
CLONIDINE HCL 101 80 21 46
METFORMIN HCL 91 86 22 6
ATORVASTATIN CALCIUM 88 82 23 13
ENALAPRIL MALEATE 87 87 24 35
LOSARTAN POTASSIUM 82 76 25 11
ISOSORBIDE MONONITRATE ER 80 66 26 56
RAMIPRIL 80 65 26 101
METOPROLOL SUCCINATE 77 77 28 18
GLIPIZIDE 75 65 29 41
RISPERIDONE 74 74 30 83
RANITIDINE HCL 74 66 30 29
LANTUS 73 58 32 59
IPRATROPIUM-ALBUTEROL 69 52 33 150
ACETYLCYSTEINE 69 26 33 624
DIOVAN 68 57 35 40
HYDROCHLOROTHIAZIDE 68 62 35 9
ROPINIROLE HCL 68 61 35 151
ALENDRONATE SODIUM 67 67 38 23
HYDROCODONE-ACETAMINOPHEN 64 52 S3 39 12
TRIAMTERENE-HCTZ 64 64 39 58
ATENOLOL 59 55 41 10
SERTRALINE HCL 59 46 41 27
OXYBUTYNIN CHLORIDE 59 54 41 107
TAMSULOSIN HCL 57 57 44 28
KLOR-CON M20 54 54 45 121
PLAVIX 54 51 45 39
NIFEDIPINE ER 51 45 47 67
EXELON 50 50 48 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.